OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically melanoma, Merkel cell lymphoma, and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on electroporation and in pre-clinical and clinical data demonstrated safety and efficacy. OMS is undergoing a phase II study for patients with late-stage metastatic melanoma. For further information, visit the company’s Web site at www.oncosec.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: